George R. Seage usually deals with Demography and limits it to topics linked to Population and Environmental health. George R. Seage combines topics linked to Population with his work on Environmental health. As part of his studies on Human immunodeficiency virus (HIV), George R. Seage frequently links adjacent subjects like Virology. While working in this field, George R. Seage studies both Virology and Immunology. He performs multidisciplinary study on Immunology and Virus in his works. George R. Seage performs multidisciplinary study in Virus and Viral disease in his work. His research is interdisciplinary, bridging the disciplines of Human immunodeficiency virus (HIV) and Viral disease. George R. Seage undertakes interdisciplinary study in the fields of Antibody and Seroconversion through his works. George R. Seage performs integrative Seroconversion and Antibody research in his work.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Essentials of Epidemiology in Public Health
Ann Aschengrau;George R. Seage.
(2013)
Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.
S L Gortmaker;M Hughes;J Cervia;M Brady.
The New England Journal of Medicine (2001)
Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
A. David Paltiel;Milton C. Weinstein;April D. Kimmel;George R. Seage.
The New England Journal of Medicine (2005)
The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
Kenneth A. Freedberg;Elena Losina;Milton C. Weinstein;A. David Paltiel.
The New England Journal of Medicine (2001)
The lifetime cost of current human immunodeficiency virus care in the United States.
Bruce R. Schackman;Kelly A. Gebo;Rochelle P. Walensky;Elena Losina.
Medical Care (2006)
Estimating the lost benefits of antiretroviral drug use in South Africa.
Pride Chigwedere;George R Seage;Sofia Gruskin;Tun-Hou Lee.
Journal of Acquired Immune Deficiency Syndromes (2008)
Randomized Controlled Trial of Audio Computer-assisted Self-Interviewing: Utility and Acceptability in Longitudinal Studies
David S. Metzger;Beryl Koblin;Charles Turner;Helen Navaline.
American Journal of Epidemiology (2000)
Duration of human immunodeficiency virus infection before detection of antibody.
C. Robert Horsburgh;Janine Jason;Ira M. Longini;Kenneth H. Mayer.
The Lancet (1989)
Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
Philimon Gona;Russell B. Van Dyke;Paige L. Williams;Wayne M. Dankner.
JAMA (2006)
HIV Preexposure Prophylaxis in the United States: Impact on Lifetime Infection Risk, Clinical Outcomes, and Cost-Effectiveness
A. David Paltiel;Kenneth A. Freedberg;Callie A. Scott;Bruce R. Schackman.
Clinical Infectious Diseases (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Fenway Health
Harvard University
Brigham and Women's Hospital
Harvard University
Harvard University
Harvard University
Rutgers, The State University of New Jersey
University of California, San Diego
University of California, San Francisco
New York Blood Center
Waseda University
Eindhoven University of Technology
Korea University
Kyoto University
Soochow University
University of Auckland
Harvard University
Salk Institute for Biological Studies
University of Oxford
Potsdam Institute for Climate Impact Research
Medical University of Vienna
University of Regensburg
University of South Florida
University of Oslo
Johns Hopkins University
University of Colorado Denver